Antiviral effect of lymphoblastoid interferon‐alpha on hepatitis C virus in patients with chronic hepatitis type C

Journal of Gastroenterology and Hepatology

Volumn 9, Issue 2, 1994, Pages 128-133

  CHAYAMA, KAZUAKI ^a   ARASE, YASUJI ^a   KOIDA, ISAO ^a   TSUBOTA, AKIHITO ^a   SAITOH, SATOSHI ^a   IKEDA, KENJI ^a   MATSUMOTO, TOYOMI ^a   KANDA, MASUMI ^a   IWASAKI, SATOMI ^a   KOBAYASHI, MARIKO ^a   HASHIMOTO, MICHIE ^a   UNAKAMI, MASAMITSU ^a   MORINAGA, TSUTO ^b   KUMADA, HIROMITSU ^a  

^a TORANOMON HOSPITAL   (Japan)

^b TEIJIN LTD   (Japan)

Author keywords

competitive PCR; genotype; HCV RNA

Indexed keywords

ALPHA INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS A; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0028197534     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1994.tb01231.x     Document Type: Article

References (25)

1. Isolation of a cDNA clone derived from a blood‐borne non‐A, non‐B viral hepatitis genome
2. An assay for circulating antibodies to a major etiologic virus of human non‐A, non‐B hepatitis
3. Transfusion associated non‐A, non‐B hepatitis: The first decade
4. Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis
5. Long‐term follow‐up of chronic posttransfusion non‐A, non‐B hepatitis: clinical and histologic outcome
6. Long‐term follow‐up of acute and chronic non‐A, non‐B posttransfusion hepatitis: Evidence of progression to liver cirrhosis
7. Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
8. Treatment of chronic hepatitis C with recombinant IFN alpha. A multicenter randomized, controlled trial
9. Recombinant IFN alpha therapy for chronic hepatitis C. A Randomized, double‐blind, placebo‐controlled trial
10. Randomised controlled trial of interferon alpha (lymphoblastoid interferon) in chronic non‐A, non‐B hepatitis
11. Effect of IFN administration on serum hepatitis C virus RNA in patients with chronic hepatitis C
12. Comparison of 1 or 3 MU of IFN alpha‐2b and placebo in patients with chronic non‐A, non‐B hepatitis
13. Recombinant human alpha‐IFN in patients with chronic non‐A, non‐B hepatitis: A multicenter randomized controlled trial from France
14. Quantitative analysis of hepatitis C virus in patients with chronic hepatitis C
15. Genotypic subtyping of hepatitis C virus
16. Avoiding false positives with PCR
17. Formulation and and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
18. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
19. IFN therapy for chronic hepatitis C
20. The relationship between the amount of hepatitis C virus quantified by competitive RT‐PCR (CRT‐PCR) and the effect of IFN treatment
21. Effect of alpha‐IFN therapy on hepatitis C viraemia in community‐acquired chronic non‐A, non‐B hepatitis
22. Randomized, double‐blind, placebo‐controlled trial of eight‐week course of recombinant alpha‐IFN for chronic non‐A, non‐B hepatitis Dig
23. Can the response to IFN treatment be predicted in patients with chronic active hepatitis C
24. Clinical backgrounds of the patients having different types of hepatitis C virus genomes